Orthofix International | OFIX - Sales Revenues


Orthofix International reported $219.91M in Sales Revenues for its fiscal quarter ending in December of 2025.





Sales Change Date
Accuray USD 116.17M 14.63M Dec/2024
AngioDynamics USD 79.43M 3.72M Sep/2025
Artivion USD 115.99M 2.6M Dec/2025
AtriCure USD 153.6M 12.4M Jun/2026
Dexcom USD 1.31B 120M Jun/2026
EDAP TMS EUR 15.42M 1.54M Mar/2026
Globus Medical USD 789.61M 29.76M Jun/2026
Inogen USD 74.93M 504K Sep/2024
Insulet USD 801.7M 40M Jun/2026
Integra LifeSciences USD 418.8M 26.9M Jun/2026
J&J USD 25.31B 1.21B Jun/2026
Medtronic USD 9.8B 800M Mar/2026
Mesa Laboratories USD 62.84M 5.01M Dec/2024
Orthofix International USD 219.91M 14.28M Dec/2025
Plus Therapeutics USD 1.03M 339K Mar/2026
Smith & Nephew USD 1.6B 1.58B Jun/2026
STAAR Surgical USD 93.5M 0 Jun/2026
Stryker USD 6.6B 600M Jun/2026
Tandem Diabetes Care USD 254.6M 7.38M Jun/2026
Teleflex USD 570.3M 22M Jun/2026
Veracyte USD 150.32M 11.25M Jun/2026
Zimmer Biomet Holdings USD 2.18B 90M Jun/2026